tiprankstipranks
Trending News
More News >
Bristol-Myers Squibb (DE:BRM)
XETRA:BRM

Compare Bristol-Myers Squibb (BRM) vs. Competitors

Compare
19 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Bristol-Myers Squibb
€49.66
€101.30B
15.61
-10.13%
8 Buy
11 Hold
1 Sell
Moderate Buy
Amgen
$347.80
$187.49B
22.84
10.40%
12 Buy
11 Hold
1 Sell
Moderate Buy
Gilead Sciences
$137.21
$170.34B
17.94
29.60%
16 Buy
5 Hold
0 Sell
Strong Buy
GlaxoSmithKline
$51.84
$104.08B
28.75
31.54%
1 Buy
3 Hold
1 Sell
Hold
Merck & Company
$114.18
$282.30B
14.46
20.53%
13 Buy
6 Hold
0 Sell
Moderate Buy
Pfizer
$26.97
$153.36B
18.21
2.98%
7 Buy
12 Hold
2 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:BRM
Bristol-Myers Squibb
49.66
-3.86
-7.20%
AMGN
Amgen
347.80
42.98
14.10%
GILD
Gilead Sciences
137.21
33.24
31.96%
GSK
GlaxoSmithKline
51.84
14.75
39.76%
MRK
Merck & Company
114.18
25.11
28.19%
PFE
Pfizer
26.97
2.60
10.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts